Corestem Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Corestem Inc with three other
companies in this sector in South Korea:
Eu Biologics Co Ltd
sales of 24.89 billion Korean Won [US$20.46 million]
of which 91%
ISU Abxis Company Limited
(16.75 billion Korean Won [US$13.76 million]
of which 99%
was Antibody Medicine), and
(13.70 billion Korean Won [US$11.26 million]
of which 100%
was Biotechnology Research&Development).
Corestem Inc reported sales of 22.32 billion Korean Won (US$18.34 million)
December of 2018.
increase of 23.3%
versus 2017, when the company's sales were 18.09 billion Korean Won.
Sales of the Clinical Trial Agent saw an increase
26.3% in 2018, from
15.40 billion Korean Won to 19.45 billion Korean Won.